Zobrazeno 1 - 10 of 494 pro vyhledávání: '"Wan HI"'
1
Akademický článek
THE TWO VERSIONS OF "HI SIKE, AL WAN HI SINGE"
Autor: Hallwas, John E.
Publikováno v: Neuphilologische Mitteilungen, 1976 Jan 01. 77(3), 360-364.
Externí odkaz: https://www.jstor.org/stable/43343068
Zobrazit plný text záznamu
2
Akademický článek
Effects of Exergaming on College Students' Situational Interest, Self-Efficacy, and Motion Sickness.
Autor: Lawrence MR; College of Biological Sciences, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA., Wan HI; School of Kinesiology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA., Liu W; Department of Physical Education, Shanghai Jiao Tong University, Shanghai 200240, China., McDonough DJ; School of Public Health, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA., Mishra S; Department of Population Health, NYU Grossman School of Medicine, New York, NY 10016, USA., Gao Z; School of Kinesiology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA.
Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Feb 25; Vol. 11 (5). Date of Electronic Publication: 2022 Feb 25.
Zobrazit plný text záznamu
3
Akademický článek
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Autor: Lakhani NJ; START Midwest, Grand Rapids, MI, USA., Chow LQM; Department of Oncology, University of Washington, Seattle, WA, USA; Department of Oncology University of Texas, Austin, TX, USA., Gainor JF; Massachusetts General Hospital Cancer Center, Boston, MA, USA., LoRusso P; Yale Cancer Center, New Haven, CT, USA., Lee KW; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Chung HC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Lee J; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea., Bang YJ; Seoul National University College of Medicine, Seoul, Korea., Hodi FS; Dana Farber Cancer Center, Boston, MA, USA., Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea., Santana-Davila R; Department of Oncology, University of Washington, Seattle, WA, USA., Fanning P; ALX Oncology, South San Francisco, CA, USA., Squifflet P; International Drug Development Institute, Brussels, Belgium., Jin F; ALX Oncology, South San Francisco, CA, USA., Kuo TC; ALX Oncology, South San Francisco, CA, USA., Wan HI; ALX Oncology, South San Francisco, CA, USA., Pons J; ALX Oncology, South San Francisco, CA, USA., Randolph SS; ALX Oncology, South San Francisco, CA, USA. Electronic address: srandolph@alxoncology.com., Messersmith WA; University of Colorado Cancer Center, Aurora, CO, USA.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2021 Dec; Vol. 22 (12), pp. 1740-1751. Date of Electronic Publication: 2021 Nov 15.
Zobrazit plný text záznamu
4
Akademický článek
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Autor: Kuo TC; ALX Oncology, Burlingame, CA, USA. tracy@tallactx.com.; Tallac Therapeutics, Burlingame, CA, USA. tracy@tallactx.com., Chen A; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA., Harrabi O; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA., Sockolosky JT; ALX Oncology, Burlingame, CA, USA.; Genentech, South San Francisco, CA, USA., Zhang A; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Sangalang E; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA., Doyle LV; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA., Kauder SE; ALX Oncology, Burlingame, CA, USA.; Coherus BioSciences, Redwood City, CA, USA., Fontaine D; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA., Bollini S; ALX Oncology, Burlingame, CA, USA., Han B; ALX Oncology, Burlingame, CA, USA.; ProLynx Inc., San Francisco, CA, USA., Fu YX; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Sim J; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA., Pons J; ALX Oncology, Burlingame, CA, USA., Wan HI; ALX Oncology, Burlingame, CA, USA.; Tallac Therapeutics, Burlingame, CA, USA.
Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2020 Nov 30; Vol. 13 (1), pp. 160. Date of Electronic Publication: 2020 Nov 30.
Zobrazit plný text záznamu
5
Akademický článek
Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing.
Autor: Kim TY; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Seoul, South Korea., Yoon MS; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, South Korea., Hustinx H; Interregional Blood Transfusion SRC Ltd., Berne, Switzerland., Sim J; ALX Oncology, Burlingame, California., Wan HI; ALX Oncology, Burlingame, California., Kim H; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, South Korea.
Publikováno v: Transfusion [Transfusion] 2020 Oct; Vol. 60 (10), pp. 2399-2407. Date of Electronic Publication: 2020 Aug 20.
Zobrazit plný text záznamu
6
Akademický článek
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile.
Autor: Kauder SE; ALX Oncology, Burlingame, CA, United States of America., Kuo TC; ALX Oncology, Burlingame, CA, United States of America., Harrabi O; ALX Oncology, Burlingame, CA, United States of America., Chen A; ALX Oncology, Burlingame, CA, United States of America., Sangalang E; ALX Oncology, Burlingame, CA, United States of America., Doyle L; ALX Oncology, Burlingame, CA, United States of America., Rocha SS; ALX Oncology, Burlingame, CA, United States of America., Bollini S; ALX Oncology, Burlingame, CA, United States of America., Han B; ALX Oncology, Burlingame, CA, United States of America., Sim J; ALX Oncology, Burlingame, CA, United States of America., Pons J; ALX Oncology, Burlingame, CA, United States of America., Wan HI; ALX Oncology, Burlingame, CA, United States of America.
Publikováno v: PloS one [PLoS One] 2018 Aug 22; Vol. 13 (8), pp. e0201832. Date of Electronic Publication: 2018 Aug 22 (Print Publication: 2018).
Zobrazit plný text záznamu
7
Akademický článek
Hippocampal function in schizophrenia and bipolar disorder.
Autor: Hall J, Whalley HC, Marwick K, McKirdy J, Sussmann J, Romaniuk L, Johnstone EC, Wan HI, McIntosh AM, Lawrie SM
Publikováno v: Psychological Medicine; May2010, Vol. 40 Issue 5, p761-770, 10p
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Molecular analyses of zebrafish V0v spinal interneurons and identification of transcriptional regulators downstream of Evx1 and Evx2 in these cells.
Autor: England, Samantha J.1 (AUTHOR), Rusnock, Amber K.1 (AUTHOR), Mujcic, Amra1 (AUTHOR), Kowalchuk, Angelica1 (AUTHOR), de Jager, Sarah2 (AUTHOR), Hilinski, William C.1 (AUTHOR), Juárez-Morales, José L.1,3 (AUTHOR), Smith, Matthew E.1 (AUTHOR), Grieb, Ginny1 (AUTHOR), Banerjee, Santanu4 (AUTHOR), Lewis, Katharine E.1 (AUTHOR) kelewi02@syr.edu
Publikováno v: Neural Development. 11/28/2023, Vol. 18 Issue 1, p1-45. 45p.
Zobrazit plný text záznamu
10
Akademický článek
The characteristics of physical activity and gait in patients receiving radiotherapy in cancer induced bone pain.
Autor: Sande TA; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Technology and Science (NTNU), Trondheim, Norway. Electronic address: tonje.laugsand@ntnu.no., Scott AC; University of Edinburgh, Edinburgh Cancer Research Centre, United Kingdom., Laird BJ; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Technology and Science (NTNU), Trondheim, Norway; University of Edinburgh, Edinburgh Cancer Research Centre, United Kingdom., Wan HI; Pfizer Biotherapeutics, Translational Medicine and Molecular Medicine Clinical Research, Collegeville, United States., Fleetwood-Walker SM; University of Edinburgh, Royal Dick Vet School, United Kingdom., Kaasa S; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Technology and Science (NTNU), Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, University Hospital of Trondheim, Trondheim, Norway., Klepstad P; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Technology and Science (NTNU), Trondheim, Norway; St. Olavs Hospital, University Hospital of Trondheim, Department of Anaesthesiology and Emergency Medicine, Trondheim, Norway., Mitchell R; University of Edinburgh, Centre for Integrative Physiology,Edinburgh, United Kingdom., Murray GD; University of Edinburgh, Centre for Population Health Sciences, Edinburgh, United Kingdom., Colvin LA; University of Edinburgh, Department of Anaesthesia and Pain Medicine, Western General Hospital, Edinburgh, United Kingdom., Fallon MT; University of Edinburgh, Edinburgh Cancer Research Centre, United Kingdom.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2014 Apr; Vol. 111 (1), pp. 18-24. Date of Electronic Publication: 2013 Nov 11.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje